La Jolla Pharmaceutical Company has named four physicians to its LJPC-401 advisory board, including gastroenterologist Paul Adams, MD.
The LJPC-401 advisory board focuses on the company's development of hepcidin. Dr. Adams is a professor of medicine and chief of gastroenterology at the University of Western Ontario in London, Ontario. The company also added:
• Victor Gordeuk, MD
• Ashutosh Lal, MD
• Gordon McLaren, MD